Akari Therapeutics (AKTX) had the highest return between 2012 and 2014 by a US stock, returning 153,599,900%.

ASSET	YEARS	% RETURN
Akari Therapeutics (AKTX)	2012-2014	153,599,900%
TCTM Kids IT Education (VSA)	2012-2014	83,093,112.5%
QXO (QXO)	2012-2014	14,784,550%
Processa Pharmaceuticals (PCSA)	2012-2014	2,566,566.67%
Aurora Cannabis (ACB)	2012-2014	1,403,950.67%
Nutex Health (NUTX)	2012-2014	399,900%
Versus Systems Inc. (VS)	2012-2014	163,639.24%
Anfield Energy (AEC)	2012-2014	94,836.71%
Prairie Operating Co Common Stock (PROP)	2012-2014	80,113.91%
Cementos Pacasmayo SAA ADR (CPAC)	2012-2014	11,902.35%
Actinium Pharmaceuticals (ATNM)	2012-2014	5,789.99%
Supercom (SPCB)	2012-2014	4,704.79%
Xpel (XPEL)	2012-2014	3,291.11%
Vipshop (VIPS)	2012-2014	3,156.64%
Avita Medical (RCEL)	2012-2014	3,029.73%
ACADIA Pharmaceuticals (ACAD)	2012-2014	2,786.36%
Par Pacific (PARR)	2012-2014	2,608.33%
Aurinia Pharmaceuticals (AUPH)	2012-2014	2,326.67%
INVO Fertility (IVF)	2012-2014	2,263.64%
Nixxy (NIXX)	2012-2014	2,060%
Puma Biotechnology (PBYI)	2012-2014	1,792.7%
Natural Health Trend (NHTC)	2012-2014	1,667.5%
Interlink Electronics (LINK)	2012-2014	1,220.12%
Netcapital (NCPL)	2012-2014	1,150%
Alnylam Pharmaceuticals (ALNY)	2012-2014	1,064.47%